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Objective: It has been suggested that positive psychotic symptoms reﬂect ‘aberrant salience’. Previously we pro-
vided support for this hypothesis in ﬁrst-episode schizophrenia patients, demonstrating that delusional symp-
toms were associated with aberrant reward processing, indexed by the Salience Attribution Test (SAT). Here
we tested whether salience processing is abnormal in schizophrenia patients with long-standing treatment-
refractory persistent delusions (TRS).
Method: Eighteen medicated TRS patients and 31 healthy volunteers completed the SAT, on which participants
made a speeded response to earnmoney in the presence of cues. Each cue comprised two visual dimensions, col-
our and form. Reinforcement probability varied over one of these dimensions (task-relevant), but not the other
(task-irrelevant).
Results: Participants responded signiﬁcantly faster on high-probability relative to low-probability trials,
representing implicit adaptive salience; this effect was intact in TRS patients. By contrast, TRS patients were im-
paired on the explicit adaptive salience measure, rating high-probability stimuli less likely to be associated with
reward than controls. There was little evidence for elevated aberrant salience in the TRS group.
Conclusion: These ﬁndings do not support the hypothesis that persistent delusions are related to aberrant moti-
vational salience processing in TRS patients. However, they do support the view that patients with schizophrenia
have impaired reward learning.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Advances in understanding the role of dopamine in reward learning
support the hypothesis that psychotic symptoms reﬂect the formation
of abnormal stimulus-reinforcement associations (Kapur, 2003). It is
well established that mesolimbic dopamine transmission is involved
in predicting rewarding events and coding outcome expectancies
(Berridge, 2007; Wise, 2004). Stimuli that are repeatedly paired with a
reward, termed conditioned stimuli (CS+), are able to elicit phasic do-
pamine ﬁring in the midbrain when presented alone, while uncondi-
tioned stimuli (CS−) that do not predict reward do not elicit such a
response (Schultz et al., 1997). It has been shown, in humans and in an-
imals, that presentation of a CS+ leads to increased response vigour44 20 7916 8517.
. This is an open access article undercompared to the presentation of a CS− (Cools et al., 2008; Roiser
et al., 2006; Talmi et al., 2008; Wyvell and Berridge, 2000), an effect
that is modulated by ventral striatal dopamine (Wyvell and Berridge,
2000). This effect has been interpreted as reﬂecting ‘motivational sa-
lience’ (Berridge and Robinson, 1998; Milstein and Dorris, 2007).
A number of theorists have suggested that the formation of abnor-
mal stimulus-reinforcement associations in schizophrenia might be re-
lated to dysregulated dopamine transmission in the ventral striatum
(Gray et al., 1991; King et al., 1984; Shaner, 1999; Snyder, 1976).
Disrupted motivational salience processing has been proposed to con-
tribute to the development of abnormal beliefs in psychotic disorders,
and in particular in patients with schizophrenia (Corlett et al., 2007;
Hemsley, 1993; King et al., 1984; Maher, 1974; Miller, 1976; Shaner,
1999). Kapur (2003) proposed the aberrant salience hypothesis of psy-
chosis, suggesting that the positive symptoms of schizophrenia may
arise from the aberrant assignment of salience to external objects and
internal representations, via context-independent stimulus-the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(Seeman and Kapur, 2000). This model also proposes that antipsychotic
medications contribute to the resolution of positive symptoms by atten-
uating aberrant motivational salience, via blockade of the dopamine D2
receptor (Kapur, 2003). However, a necessary corollary of this is that
antipsychotic medication will also necessarily attenuate adaptive (ap-
propriate) motivational salience which may result in negative side-
effects related to loss of motivation, such as apathy and anhedonia.
Consistent with this model, numerous studies have demonstrated
reinforcement learning deﬁcits in schizophrenia (Gold et al., 2008;Mur-
ray et al., 2008b;Waltz et al., 2007;Waltz and Gold, 2007), although the
patients included in these studies were mostly receiving medication;
important because anti-psychotic medication is known to disrupt re-
ward processing in healthy volunteers (Pessiglione et al., 2006). Find-
ings of abnormal haemodynamic response patterns in regions strongly
innervated by dopamine during reward processing in patientswith psy-
chosis, including in unmedicated patients, provide convergent support
for the aberrant salience hypothesis (Jensen et al., 2008; Juckel et al.,
2006; Murray et al., 2008a); though interestingly a recent longitudinal
neuroimaging study demonstrated relatively normalised haemody-
namic responses during the anticipation of uncertain rewards following
6 weeks' treatment with an atypical antipsychotic (amisulpride) in ini-
tially treatment-naïve patients (Nielsen et al., 2012).
Roiser et al. (2009) provided the ﬁrst evidence linking aberrant re-
ward learning with delusions, as predicted by the aberrant salience hy-
pothesis, using a novel behavioural paradigm, the Salience Attribution
Test (SAT), designed speciﬁcally to assess processing pertaining to irrel-
evant stimuli. First-episode schizophrenia patients with delusions
scored higher on the SAT “explicit aberrant salience” measure (task-ir-
relevant reward learning) than those without such symptoms. Consis-
tent with the above-mentioned studies they also identiﬁed impaired
“adaptive salience” (task-relevant reward learning) in these predomi-
nantly medicated patients with ﬁrst-episode schizophrenia. More re-
cently, Roiser et al. (2013) reported elevated aberrant salience in
“prodromal” individuals, who are at high risk of the development of
psychosis because they experience attenuated psychotic symptoms
(for example, suspicious ideas or unusual perceptual experiences), but
do not (yet) meet criteria for psychosis. Interestingly, the degree of ab-
errant salience measured by the SAT correlated positively with
delusion-like symptoms in that sample.
Importantly, Roiser et al. (2009) did not demonstrate a signiﬁ-
cant difference in aberrant salience between healthy volunteers
and patients with ﬁrst-episode schizophrenia. However, that study
included a heterogeneous sample with only 65% of patients actually
reporting delusions at the time of testing, with moderate severity. If
a relationship between aberrant salience and delusions does indeed
exist, it was anticipated that selecting a symptomatically homoge-
neous sample of patients with severe delusions would reduce vari-
ability and thereby increase the chance of ﬁnding a difference
between patients with schizophrenia and healthy volunteers.
Hence, the patients recruited for the present study were receiving
medication but still exhibiting ﬂorid positive psychotic symptoms,
speciﬁcally delusions.
1.1. Aims of the study
The aimof the current studywas to testwhethermotivational salience
processing was abnormal in schizophrenia patients experiencing persis-
tent delusions. On the basis of the aberrant salience hypothesis we
made the following predictions:
1. Patients experiencing persistent delusions would exhibit greater ab-
errant salience than healthy volunteers, reﬂecting a pathological
neurobiological mechanism maintaining their delusions;2. Patients experiencing persistent delusions would exhibit reduced
adaptive salience relative to healthy volunteers, reﬂecting a corollary
of anti-psychotic medication.2. Methods
2.1. Participants
Eighteen patients with schizophrenia who had long-standing
treatment-refractory persistent delusions (TRS) were recruited from
ﬁve mental health rehabilitation units within an inner city UK National
Health Service Trust. Eligible patientswere invited to participate follow-
ing review of their clinical notes and discussion with their psychiatrist.
This Trust serves a populationwith one of the highest levels of psychiat-
ric morbidity in the UK and provides a full range of inpatient and com-
munity based services. People receiving inpatient mental health
rehabilitation (who were the target of recruitment for the present
study) are thosewith especially complex psychosis (treatment resistant
positive and/or negative symptoms, often with mental and physical
health comorbidities) who require specialist treatment due to the se-
verity of their illness.
Patients were recruited if theywere aged 18–65 years. The inclusion
criteria were a DSM-IV diagnosis of schizophrenia and the presence of
persistent delusions despite adequate treatment with at least two anti-
psychotic drugs at therapeutic doses for at least 6 weeks (Table 1). Pa-
tients of these rehabilitation services had been in contact with mental
health services from 15 to 30 years, with amean of ﬁve previous admis-
sions to hospital and had spent between ﬁve months and ﬁve years in
their current unit (Killaspy et al., 2008). Symptom type and severity
were assessed in patients at the time of testing using the Scales for the
Assessment of Positive Symptoms – SAPS (Andreasen, 1983) and Nega-
tive Symptoms – SANS (Andreasen, 1981), the Calgary Depression Rat-
ing Scale for Schizophrenia – CDRSS (Addington et al., 1990) and the
Young Mania Scale – YMRS (Young et al., 1978).
All patients weremedicated at the time of testing. Total antipsychot-
ic medication load was computed as a percentage of the maximum rec-
ommended British National Formulary (BNF: www.bnf.org) dose,
summing percentages for different antipsychotics where appropriate.
Eight patients were taking one atypical antipsychotic, two were taking
two atypical antipsychotics, threewere taking one atypical antipsychot-
ic and onemood stabiliser (e.g. sodiumvalproate), fourwere taking two
atypical antipsychotics and one mood stabiliser, and one patient was
taking one atypical antipsychotic, one typical antipsychotic (haloperi-
dol), and one mood stabiliser. In total eight patients were taking
clozapine.
Patients were comparedwith thirty-one healthy volunteers, recruit-
ed via advertisement. Exclusion criteria were: known psychiatric or
neurological disorder; medical disorder likely to lead to cognitive im-
pairment; intelligence quotient (IQ) b70; and recent illicit substance
use. The absence of axis-I psychopathology and alcohol- or substance-
abuse/dependence was conﬁrmed with the Mini International Neuro-
psychiatric Inventory (Sheehan et al., 1998). Dimensions of schizotypy
were measured in the healthy volunteers using the short form of the
Oxford-Liverpool Inventory of Feelings and Experiences schizotypy
questionnaire – O-LIFE (Mason et al., 2005). Ethical approval was ob-
tained from the Ealing & West London Mental Health Trust Research
Ethics Committee. All participants provided written informed consent,
and were compensated £40 for their time and travel expenses.
2.2. Experimental paradigm – Salience Attribution Test (SAT)
The SAT is a speeded reaction time task in which participants re-
spond to a probe (a black square) following presentation of a cue in
Table 1
Demographic, personality and clinical measures.
Controls (N = 31) N Patients (N = 18) N Statistic
Gender (male/female) 21/10 31 14/4 18 χ 2(1) = 0.562, P = 0.453
Age, years 36.80 (11.32) 31 41.82 (12.25) 17* t(35) = 1.426, P = 0.160
Estimated full scale IQ (WTAR or NART) 96.55 (9.14) 31 91.13 (13.38) 15** t(33) = 1.481, P = 0.146
O-LIFE Unusual Experiences 2.80 (3.32) 31 - - -
O-LIFE Cognitive Disorganization 3.48 (2.91) 31 - - -
O-LIFE Introvertive Anhedonia 1.67 (1.75) 31 - - -
O-LIFE Impulsive Nonconformity 2.45 (2.12) 31 - - -
SAPS global - - 7.17 (2.60) 18 -
SANS global - - 5.72 (3.71) 18 -
Delusions - global severity - - 3.94 (0.73) 18 -
Hallucinations - global severity - - 2.22 (2.05) 18 -
Antipsychotic intake (% of maximum BNF dose) - - 69.3 (43.9) 18 -
Values representmeans (standarddeviations). Abbreviations: IQ, intelligence quotient;WTAR,Wechsler test of adult reading;NART,National Adult Reading Test; O-LIFE, Oxford-Liverpool
Inventory of Feelings and Experiences; SAPS, Scale for the Assessment of Positive Symptoms; SANS, Scale for the Assessment of Negative Symptoms; BNF, British National Formulary. *
denotes age data missing from one patient. ** denotes IQ data missing from 3 patients: one patient was dyslexic; one patient did not have English as their ﬁrst language; and one patient's
data were not recorded. The proportion of participants tested with the WTAR (controls: N = 21; patients: N = 7) and the NART (controls: N = 10; patients: N = 8) did not differ sig-
niﬁcantly between the groups (χ21 = 1.885, P = 0.170).
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in the Supplementary Online Materials.
Participants completed two blocks of 64 trials, where money was
available on 50% of trials. On each trial, the likelihood that money was
available was signalled by one of four cues that appeared at the top
and bottom of the screen just before the onset of the probe (the black
square). Four different types of cues were used: red animals; blue ani-
mals; red household objects and blue household objects, which varied
across two dimensions - colour (blue or red) and form (animal or
household object). One of the dimensions (for example, colour) was
task-relevant so that one level of the dimension (for example blue)
was reinforced on 28 out of 32 (87.5%) of the trials, while only 4 out
of 32 (12.5%) trials of the other level were reinforced. The other dimen-
sion, in this example form,was task-irrelevant, so that 16 out of 32 (50%)
of both levels (animals and household objects) were reinforced. Four
different versions of the SAT were used, each with a different stimulus
feature (blue, red, animal or household object) reinforced with high
probability. Each participant was administered the same version (i.e.
with identical cue-reinforcement contingencies) for both blocks.
2.3. Other cognitive measures
Verbal IQ was estimated using the Wechsler Test of Adult reading –
WTAR (Wechsler, 2001) or the National Adult Reading Test – NART
(Nelson, 1982). The forwards and backwards digit span was used to
test whether patients with schizophrenia showed an (expected) im-
pairment in working memory (Wechsler, 1981).
2.4. Statistical analysis
Data were analysed using the Statistical Package for Social Sciences,
version 16 (SPSS Inc., Chicago, IL, USA). Full details are provided in the
Supplementary Online Materials.
At alpha = 0.05 (two-tailed), this study had 80% power to detect a
large effect size (d=0.85), which is of comparablemagnitude to the in-
crease in explicit aberrant salience we previously identiﬁed in individ-
uals in an at-risk mental state for psychosis, not all of whom had
delusion-like thoughts, relative to healthy volunteers (d= 0.93: Roiser
et al., 2013).
3. Results
3.1. Demographic data
The groups were matched for gender, age and IQ (Table 1).3.2. Digit span
Controls scored signiﬁcantly higher than patients on the digit span
task [main effect of group: F(1,46) = 16.616, P b 0.001], and scores
were signiﬁcantly lower in the backwards condition than the forwards
condition [main effect of stage: F(1,46) = 33.965, P b 0.001]. The
group*stage interaction was non-signiﬁcant (P N 0.1).
3.3. Salience Attribution Test (SAT)
Behavioural data are presented in Table 2.
3.4. Implicit salience
3.4.1. Adaptive salience
The control group responded signiﬁcantly faster overall than the pa-
tient group [main effect of group: F(1,47)= 19.705, P b 0.001] and par-
ticipants responded signiﬁcantly faster on block 2 than block 1 [main
effect of block: F(1,47)= 5.051, P=0.029]. Participants also responded
signiﬁcantly faster on high- relative to low-probability reinforced trials
[main effect of probability: F(1,47) = 12.222, P= 0.001], representing
implicit adaptive salience. No interactions with group approached sig-
niﬁcance (P N 0.1 for all). Both groups exhibited implicit adaptive sa-
lience (see Table 1), though this effect was only marginally signiﬁcant
in the TRS group [controls: mean = 8.85 ms, SD = 17.34 ms, t(30) =
2.841, P = 0.008; patients: mean = 12.28 ms, SD = 24.87 ms,
t(17) = 2.093, P = 0.052]. When digit span (forward) was included
as a covariate in the analysis the results were unchanged.
3.4.2. Aberrant salience
There was a signiﬁcant main effect of group [F(1,47) = 6.236, P=
0.016], but this was qualiﬁed by a signiﬁcant group*block interaction
[F(1,47) = 5.026, P = 0.030]. There was no signiﬁcant main effect of
block [F(1,47) = 0.364, P N 0.1]. Post-hoc analysis revealed that the
TRS group exhibited signiﬁcantly greater implicit aberrant salience
than controls on block 1 (P=0.001), while there was no difference be-
tween the groups on block 2 (P = 0.805). When digit span (forward)
was included as a covariate in the analysis the group*block interaction
no longer achieved signiﬁcance (P= 0.121).
3.5. Explicit salience
3.5.1. Adaptive salience (Fig. 1)
Participants rated high-probability reinforced stimuli as signiﬁcantly
more likely to yield reward than low-probability reinforced stimuli
Table 2
Behavioural data.
Test Measure Controls
(N = 31)
Patients
(N = 18)
Salience Attribution Test
Block
1
RT high probability (ms)* 250.09 (54.15) 351.12 (108.84)
RT low probability (ms)* 253.93 (56.76) 367.89 (145.97)
Implicit adaptive salience (ms) 3.84 (19.86) 16.77 (47.55)
Implicit aberrant salience
(ms)†#
12.80 (12.18) 34.07 (23.49)
VAS high probability (%)# 54.52 (17.12) 40.14 (18.95)
VAS low probability (%) 27.34 (17.65) 30.97 (18.31)
Explicit adaptive salience (%)* 27.18 (26.22) 9.17 (15.46)
Explicit aberrant salience (%) 15.08 (14.68) 10.28 (8.99)
Premature responses* 3.42 (1.98) 5.56 (4.29)
Omissions* 0.61 (1.38) 2.06 (2.10)
Block
2
RT high probability (ms)* 232.40 (43.47) 345.94 (121.28)
RT low probability (ms)* 246.26 (48.20) 353.72 (123.06)
Implicit adaptive salience (ms) 13.86 (24.86) 7.78 (21.67)
Implicit aberrant salience (ms)† 23.01 (32.65) 19.36 (13.49)
VAS high probability (%)# 59.92 (17.65) 35.00 (18.17)
VAS low probability (%) 20.65 (16.97) 28.47 (14.83)
Explicit adaptive salience (%)* 39.27 (26.57) 6.53 (12.64)
Explicit aberrant salience (%) 9.92 (15.16) 10.14 (6.99)
Premature responses* 3.10 (2.53) 4.39 (3.55)
Omissions* 0.52 (0.96) 1.44 (2.04)
Digit span
Forwards* 8.84 (2.40) 6.41 (2.29)
Backwards* 6.77 (2.55) 4.35 (1.41)
Values represent means (standard deviations). Abbreviations: RT, response time; VAS, Vi-
sual Analogue Scale. * Signiﬁcant overall main effect of group (i.e. averaging across block
and/or condition) at P b 0.05; † signiﬁcant group-by-block interaction at P b 0.05; # sig-
niﬁcant simple main effect of group at P b 0.05. Digit span data weremissing for one par-
ticipant. Digit span data were missing for one TRS patient.
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trend towards patients' ratings of reward probabilities being lower
overall than controls [main effect of group: F(1,47) = 3.834, P =
0.056]. However, these effectswere qualiﬁed by a signiﬁcant probability
x group interaction [F(1,47)=20.997, P b 0.001]. Therewas also a trend
towards a probability*group*block interaction [F(1,47) = 3.692, P =
0.061], which was not analysed further. When digit span (forward)
was included as a covariate in the analysis the main effect of group no
longer approached signiﬁcance (P= 0.167).
Post-hoc analysis of the probability*group interaction revealed that
the explicit adaptive salience scores were signiﬁcant in each group sep-
arately, suggesting that both groups displayed some learning [controls:
mean= 33.22, SD= 21.57, t(30)= 8.576, P b 0.001; patients: mean=Fig. 1. Visual analogue scale (VAS) probability ratings in schizophrenia patients with treatmen
adaptive salience (the difference in VAS rating between high and low probability stimuli) than
F(1,47)=20.997, P b 0.001]. This group differencewas driven by a reduction in the ratings for h
between the groups for the ratings of low probability stimuli. Error bars represent standard er7.85, SD= 12.03, t(17)= 2.768, P=0.013]. Further analysis suggested
that the patients were only impaired at learning about high-probability
reinforced stimuli (Fig. 1). Controls rated high probability stimuli signif-
icantly more likely to yield reward than patients (P b 0.001); by con-
trast, there was no difference between the groups for the ratings of
low probability stimuli (P= 0.206).
3.5.2. Aberrant salience
There was a trend towards a block*group interaction [F(1,47) =
3.428, P= 0.070], which was not analysed further. The main effects of
group [F(1,47) = 0.248, P = 0.621] and block [F(1,47) = 1.394, P =
0.244] were non-signiﬁcant. Mean aberrant salience scores were 10.21
(SD = 5.99) in the TRS group and 12.50 (SD = 12.15) in the controls.
When digit span (forward) was included as a covariate in the analysis
the block*group interaction no longer approached signiﬁcance (P =
0.357).
3.6. Premature responses & omission errors
Participants showed a trend towards making fewer premature re-
sponses on the second block [F(1,47) = 3.741, P= 0.059], and patients
made signiﬁcantly more premature responses than controls [main effect
of group: F(1,47) = 4.637, P= 0.036]. The block*group interaction was
non-signiﬁcant [F(1,47) = 1.202, P N 0.1]. When digit span (forward)
was included as a covariate in the analysis themain effect of block no lon-
ger approached signiﬁcance (P = 0.157). Patients made signiﬁcantly
more omission errors than the controls (P= 0.004), but the main effect
of block was non-signiﬁcant (P= 0.131).
3.7. Correlations
There were no correlations that approached signiﬁcance (P b 0.05)
between salience scores and symptom or schizotypy scores.
Across both groups explicit adaptive salience correlated signiﬁcantly
with IQ (r=0.41, P=0.005). This correlationwas also signiﬁcant in the
TRS group alone (r = 0.66, P = 0.008). Further analysis revealed that
this relationship was driven by a signiﬁcant (negative) relationship be-
tween IQ and VAS ratings for low probability stimuli (all subjects: r=
−0.51, P b 0.001; controls: r = −0.43, P = 0.015; TRS: r = −0.59,
P=0.021), while there was no correlation between IQ and VAS ratings
for high probability stimuli (rs b0.1 in each group). No correlations with
IQ approached signiﬁcance for any other SAT measure (all rs b0.3).
There was a trend towards a positive correlation between implicit
adaptive salience and antipsychotic medication intake (r = 0.53, P =
0.022). There was also a trend towards a positive correlation betweent-resistant delusions (TRS) and controls. Controls exhibited signiﬁcantly greater explicit
TRS patients [controls: mean = 33.22, SD = 21.57; patients: mean = 7.85, SD = 12.03;
igh probability stimuli in TRS patients (* indicates P b 0.001), while therewas no difference
rors of the mean.
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(r= 0.53, P= 0.025). The relationship with medication intake did not
approach signiﬁcance for any other SAT measure (all rs b0.5).
4. Discussion
We investigated the learning of stimulus-reinforcement associations
in TRS patients with chronic delusions and healthy controls using the
SAT. As predicted, TRS patients exhibited reduced explicit adaptive sa-
lience relative to healthy controls. Contrary to our predictions, however,
the data did not suggest reduced implicit adaptive salience or elevated
aberrant salience in the TRS patients. These data do not support the hy-
pothesis that persistent delusions in TRS patients are associated with
aberrant attributions of motivational salience to external stimuli, or
that antipsychotic medication causes an implicit motivational deﬁcit
(Kapur, 2003).
The analysis of VAS ratings revealed that participants across both
groups rated high-probability-reinforced stimuli signiﬁcantly more
likely to yield reward than low-probability-reinforced stimuli. How-
ever, consistent with our previous study (Roiser et al., 2009), TRS pa-
tients' explicit adaptive salience scores were signiﬁcantly lower than
those of controls. This ﬁnding is consistent with ﬁndings from sever-
al other studies (Jensen et al., 2008; Waltz et al., 2007). This impair-
ment in reward learning may be related to dopamine D2 receptor
blockade (Cutmore and Beninger, 1990), representing an undesir-
able side effect of antipsychotic medication (Schooler, 1994). The
adaptive salience scores were, nevertheless, signiﬁcant in each
group separately, suggesting that learning was not completely
abolished in the TRS group.
Across both groups, participants were signiﬁcantly faster at
responding to high- relative to low-probability-reinforced stimuli.
TRS patients were just as able to speed responses on high probability
trials as controls; implicit adaptive salience scores were even numer-
ically higher in this group and showed a positive relationship with
antipsychotic medication load (though the latter ﬁnding did not
survive the more stringent signiﬁcance threshold we adopted for
the correlational analyses). These surprising ﬁndings contradict our
second prediction, and raise the possibility that although implicit
and explicit adaptive salience correlate in normative samples (for
example, Schmidt and Roiser (2009)), they may have different neu-
robiological substrates. The control group responded signiﬁcantly
faster on the SAT than the TRS group overall, consistent with
numerous other studies (Prouteau et al., 2004).
The ﬁnding of preserved implicit adaptive salience in TRS patients is
consistentwithprevious research suggesting that poor decision-making
in schizophrenia can occur in the context of spared implicit reinforce-
ment learning. For example, Heerey et al. (2008) reported normal sen-
sitivity to reward in participants with schizophrenia using a signal
detection approach, but differences in choice patterns on a decision-
making task. Relatively intact implicit responding, in conjunction with
impaired explicit responding, has also been reported on tasks measur-
ing inhibition in schizophrenia (Huddy et al., 2009). Therefore, patients
may be sensitive to reward contingencies and able to speed responses
based on reinforcement, despite an impaired ability to differentiate
high- and low-probability stimuli explicitly.
It is also surprising that relatively intact implicit adaptive salience
was detected in TRS patients despite their taking high doses of antipsy-
chotic medication. A possible explanation relates to the medications
taken by the TRS patients: most were taking atypical antipsychotics
(nearly half were taking clozapine), which have a relatively lower afﬁn-
ity for dopamine receptors than typical antipsychotics. Interestingly, re-
cent studies suggest that atypical antipsychotics may even normalise
reward processing (Nielsen et al., 2012; Smieskova et al., 2015); other
studies have found that typical antipsychotics induce greater bluntingof striatal responses than atypical antipsychotics (Kirsch et al., 2007).
However, it should be noted that the majority of patients in our earlier
study (Roiser et al., 2009), in which implicit adaptive salience was
disrupted, were also taking atypical antipsychotics; arguing against
the notion that differences in medication underlie the different results
found between these two studies on the implicit adaptive salience
measure.
In relation to our ﬁrst hypothesis, we observed elevated implicit ab-
errant salience on the ﬁrst block only, which may reﬂect aberrant re-
ward learning, but no group differences in explicit aberrant salience.
When digit span (forward) was included as a covariate in the analysis
the group*block interaction was no longer signiﬁcant, although the
main effect of group remained. Consistent with the former result, in
one previous study we found that this measure correlated with
schizotypy in healthy volunteers (Schmidt and Roiser, 2009). However,
in our previous studies this measure has not been sensitive to the pres-
ence of psychotic symptoms. The explanation for this result is unclear,
and therefore we advise that this result is treated with caution until
replicated.
The persistence of delusions despite antipsychotic medication in
this TRS sample, and the similar explicit aberrant salience scores be-
tween the groups, may point to an alternative mechanism than aber-
rant salience underlying the maintenance of abnormal beliefs.
Possibly, dopamine-driven aberrant salience could operate in the
early phases of psychosis, but some patients may not be able to un-
learn previously learned associations, and thus delusions may be
maintained by non-dopaminergic mechanisms in TRS patients. Con-
sistent with this notion, a recent study reported that dopamine syn-
thesis, which is reliably elevated in schizophrenia and its prodrome
(Howes et al., 2009), was normal in patients who had not responded
to antipsychotic medication and remained psychotic (Demjaha et al.,
2012). Another possibility is that there may exist other cognitive dis-
tortions that precipitate the expression of delusions other than aber-
rant salience that we did not test here, for example the “jumping-to-
conclusions” bias (Garety et al., 2007) or latent inhibition (Gal et al.,
2005; Gray et al., 1995). These surprising results also have some po-
tential implications for treatment. Since this TRS population does not
appear to exhibit pronounced aberrant salience, despite the severity
of their positive symptoms, in this group it would be worthwhile
considering psychosocial interventions that focus more on behav-
ioural or goal-oriented approaches to rehabilitation than on chal-
lenging psychotic symptoms. Interestingly, recent evidence
supports this suggestion, showing that the degree to which individ-
ual inpatient mental health units focus on behavioural or goal-
oriented approaches is directly related to the likelihood of successful
community discharge (Killaspy et al., 2016).
Several limitations of our studymerit comment. First, the small sam-
ple size means that the differences between the groups may not be es-
timated accurately, and therefore we advise that these ﬁndings are
treated with caution until independently replicated. That said, our a
priori power analysis suggested thatwe did have sufﬁcient power to de-
tect a group difference of the magnitude that we have identiﬁed previ-
ously on the SAT in similar case–control studies. Second, we did not
collect racial or ethnic demographic information from our participants,
meaning that we were unable to assess whether the groups were well
matched, or representative of the wider population, on these measures.
However, in terms of age and gender, our sample was representative of
users of mental health rehabilitation services in England (Killaspy et al.,
2013). Third, as expected the groups were not matched on working
memory ability, which could conceivably affect performance on the
SAT. However, including digit span as a covariate in the analyses had lit-
tle impact on the results. Finally, all TRS patients were taking antipsy-
chotic medication. The aberrant salience hypothesis warrants further
investigation in unmedicated patients with delusional schizophrenia.
37R. Abboud et al. / Schizophrenia Research: Cognition 4 (2016) 32–38It would also be of great interest to compare patients with schizophre-
nia who do and do not respond to antipsychotic medication on mea-
sures of aberrant salience.
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